Skip to content

Effectiveness of Cognitive Behavioral Therapy (CBT) for Child Anxiety Disorders in Community Clinics in Norway

Effectiveness of Group and Individual Treatment of Childhood Anxiety Disorders in Community Clinics. A Randomized Controlled Trial.

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00735995
Enrollment
165
Registered
2008-08-15
Start date
2008-08-31
Completion date
2013-12-31
Last updated
2018-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Anxiety Disorder, Separation Anxiety Disorder, Social Phobia

Brief summary

The purpose of this study is to assess the effectiveness of a cognitive-behavioral intervention for children aged 7 to 12 years with anxiety disorders who are referred to ordinary community clinics. The treatment will be conducted as individual therapy or group therapy.

Interventions

BEHAVIORALCognitive behavioral therapy (individual)

The Coping Cat program, 12 weekly sessions, two additional parent meetings

BEHAVIORALCognitive behavioral therapy (group)

The Coping Cat program, 12 weekly sessions, two additional parent meetings

Sponsors

The Research Council of Norway
CollaboratorOTHER
Regionsenter for barn og unges psykiske helse
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
7 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Primary diagnosis of separation anxiety disorder, social phobia or generalized anxiety disorder based on the ADIS interview schedule, DSM-IV criteria

Exclusion criteria

* Pervasive Developmental Disorder * Psychotic symptoms * Intelligence score \< 70 * Use of medications with anxiety reducing effects during treatment * Neither parent competent in Norwegian language

Design outcomes

Primary

MeasureTime frame
Status of primary anxiety disorder at inclusion based on the ADIS interview schedule with parents and youthpost-treatment and 2 year follow-up

Secondary

MeasureTime frame
Symptom score on the MASCpost-treatment and 2 year follow-up
CGASpost-treatment and 2 year follow-up

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026